Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28351 - 28375 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	CNTRL	11064	upregulated	Cytarabine results in increased expression of CNTRL mRNA	9q33.2	A21886
Cytarabine	Approved Investigational	COBLL1	22837	downregulated	Cytarabine results in decreased expression of COBLL1 mRNA	2q24.3	A21886
Cytarabine	Approved Investigational	COL13A1	1305	downregulated	Cytarabine results in decreased expression of COL13A1 mRNA	10q22.1	A21886
Cytarabine	Approved Investigational	COL18A1	80781	downregulated	Cytarabine results in decreased expression of COL18A1 mRNA	21q22.3	A21886
Cytarabine	Approved Investigational	COL1A1	1277	downregulated	Cytarabine results in decreased expression of COL1A1 mRNA	17q21.33	A21886
Cytarabine	Approved Investigational	COL1A2	1278	downregulated	Cytarabine results in decreased expression of COL1A2 mRNA	7q21.3	A21886
Cytarabine	Approved Investigational	COL3A1	1281	downregulated	Cytarabine results in decreased expression of COL3A1 mRNA	2q32.2	A21886
Cytarabine	Approved Investigational	COL5A1	1289	downregulated	Cytarabine results in decreased expression of COL5A1 mRNA	9q34.3	A21886
Cytarabine	Approved Investigational	COL5A2	1290	downregulated	Cytarabine results in decreased expression of COL5A2 mRNA	2q32.2	A21886
Cytarabine	Approved Investigational	COL6A2	1292	downregulated	Cytarabine results in decreased expression of COL6A2 mRNA	21q22.3	A21886
Cytarabine	Approved Investigational	COL6A3	1293	downregulated	Cytarabine results in decreased expression of COL6A3 mRNA	2q37.3	A21886
Cytarabine	Approved Investigational	COL9A1	1297	upregulated	Cytarabine results in increased expression of COL9A1 mRNA	6q13	A21886
Cytarabine	Approved Investigational	COLEC12	81035	downregulated	Cytarabine results in decreased expression of COLEC12 mRNA	18p11.32	A21886
Cytarabine	Approved Investigational	CPZ	8532	downregulated	Cytarabine results in decreased expression of CPZ mRNA	4p16.1	A21886
Cytarabine	Approved Investigational	CRABP1	1381	upregulated	Cytarabine results in increased expression of CRABP1 mRNA	15q25.1	A21886
Cytarabine	Approved Investigational	CRISPLD2	83716	downregulated	Cytarabine results in decreased expression of CRISPLD2 mRNA	16q24.1	A21886
Cytarabine	Approved Investigational	CRTAP	10491	downregulated	Cytarabine results in decreased expression of CRTAP mRNA	3p22.3	A21886
Cytarabine	Approved Investigational	CRYAB	1410	downregulated	Cytarabine results in decreased expression of CRYAB mRNA	11q23.1	A21886
Cytarabine	Approved Investigational	CSNK1D	1453	downregulated	Cytarabine results in decreased expression of CSNK1D mRNA	17q25.3	A21886
Cytarabine	Approved Investigational	CTSH	1512	downregulated	Cytarabine results in decreased expression of CTSH mRNA	15q25.1	A21886
Cytarabine	Approved Investigational	CTSL	1514	downregulated	Cytarabine results in decreased expression of CTSL mRNA	9q21.33	A21886
Cytarabine	Approved Investigational	CXCR4	7852	upregulated	Cytarabine results in increased expression of CXCR4 mRNA	2q22.1	A20985 A21886
Cytarabine	Approved Investigational	CYB5A	1528	downregulated	Cytarabine results in decreased expression of CYB5A mRNA	18q22.3	A21886
Cytarabine	Approved Investigational	CYB5D1	124637	downregulated	Cytarabine results in decreased expression of CYB5D1 mRNA	17p13.1	A21886
Cytarabine	Approved Investigational	CYB5R2	51700	downregulated	Cytarabine results in decreased expression of CYB5R2 mRNA	11p15.4	A21886

Displaying entries 28351 - 28375 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability